Patents by Inventor Emily BALSKUS

Emily BALSKUS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220387459
    Abstract: The technology described herein is directed to methods and compositions for inhibition of ClbP and the treatment and/or prevention of cancer, e.g., colorectal cancer, a urinary tract cancer, a squamous cell carcinoma, an oral squamous cell carcinoma, or a head-and-neck cancer.
    Type: Application
    Filed: January 10, 2022
    Publication date: December 8, 2022
    Inventors: Matthew R. VOLPE, Emily BALSKUS
  • Publication number: 20220226269
    Abstract: The present disclosure relates to the use of an agent that inhibits the activity of or decreases the levels of an L-dopa decarboxylase conjointly with levodopa (L-dopa) in the treatment of a condition.
    Type: Application
    Filed: June 12, 2020
    Publication date: July 21, 2022
    Inventors: Emily Balskus, Vayu Maini Rekdal
  • Publication number: 20210128642
    Abstract: Microbes expressing cholesterol oxidoreductase (COR) proteins, methods of engineering the microbes expressing COR proteins, compositions and methods of using the microbes are provided.
    Type: Application
    Filed: September 18, 2020
    Publication date: May 6, 2021
    Inventors: Douglas KENNY, Hera VLAMAKIS, Ramnik XAVIER, Emily BALSKUS, Damian PLICHTA